We have the power to mitigate the adverse impact of rapid advancement in information technology.
Charles J. Lockwood, MD, MHCM
Almost 25% of women with breast cancer have a family history of the disease and, those who do have a higher risk of developing cancer.
As more patients turn to ob/gyns for wellness exams, physicians need to stay up-to-date on current recommendations.
In the second part of this series, potential solutions to fix the rising drug cost problem are examined.
The economic impact of drug costs and how we got here are examined in the first of a two-part series.
Faced with the rapid increase in a potentially deadly—but preventable—congenital disease, it’s time for states to take action to require appropriate screening
As more states turn to punitive policies to discourage OUD among pregnant women, Dr. Lockwood and Dr. Wolfson examine what the ob/gyn's role in the debate should be.
Ob/gyns have the mental make-up to thrive in medicine but success requires tenacity
In this interview, editor-in-chief Charles J. Lockwood reviews key changes in guidelines for preventive screening throughout a woman’s lifespan with experts in internal medicine and ob/gyn.
Leveraging maternal mortality review committees in every state is the key to reducing rising rates of maternal mortality in the United States.